Mr. Hale serves as Chairman of the Board of Clarify Medical, Inc. He is Chairman and CEO of Hale Biopharma Ventures, LLC, a private company focused on the formation and development of biotechnology, specialty pharma, diagnostic and medical device companies. He was involved in the formation and development of SkinMedica, an aesthetic skincare company, and served as Executive Chairman and Chairman from 2001 through that company’s sale to Allergan for $315 million.
Mr. Hale served as Chairman of Santarus, Inc. prior to its sale to Salix Pharmaceuticals in 2014, Micromet prior to its sale to Amgen in 2012 for $1.2 billion, Somaxon Pharmaceuticals prior to its sale to Permix in 2013, and Crisi Medical Systems prior to its sale to Becton Dickinson & Co. in 2015.
Mr. Hale is a serial entrepreneur who has been involved in the formation and/or development of many other life sciences companies. In addition to the companies above, these include Hybritech, Viagene, Gensia Sicor, CancerVax, Neurelis, MDRejuvena, Dermata, Adgica Health, Oncternal, Agility Clinical, Biocept, Neurana and Colorescience, Inc. He serves on the board of two public companies, Conatus and BIOCEPT.